UPDATE 1-Galapagos ends Merck alliance, revenue growth to slow
February 04, 2011 at 03:03 AM EST
BRUSSELS, Feb 4 (Reuters) - Belgian biotech firm Galapagos said on Friday it achieved record revenues in the final three months of 2010 but predicted a slowdown in growth for 2011 after ending an alliance with Merck & Co. .
